Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble epoxide hydrolase and peroxisome proliferator-activated receptors

Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble epoxide hydrolase and peroxisome proliferator-activated receptors

US Patent 11447445 · Granted Sep 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orally available sEH/PDE4 dual inhibitors2023
Substituted epoxyeicosatrienoic acid (EET) analogs for treatment of kidney disea2022
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2021
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2021
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2021
Diabetes and metabolic syndrome treatment with a novel dual modulator of soluble2021
Epoxyeicosatrienoic acid analogs and methods of making and using the same2016
Epoxyeicosatrienoic acid analogs and methods of making and using the same2015
Compositions and methods for the treatment of renal and cardiovascular disease2010
Compositions and methods for the treatment of renal and cardiovascular disease2009